Neurological9 residues

DSIP

Delta sleep-inducing peptide

DSIP stands for delta sleep-inducing peptide. Its name comes from the experimental setting of its discovery and is not a guarantee of a sleep effect in humans.

Reviewed September 2026

Residues
9. calculated: Count of residues in the stored canonical reference sequence; terminal groups are not extra residues.
Average mass
848.81 Da. calculated: Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded.
pI
4.09 (theoretical). calculated: Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation.

Primary structure

Sequence

N-terminusC-terminus
TryptophanTrp · WOpen amino-acid reference

Peptide. Sequence describes the reference peptide, not a tested supplier lot.

Calculated properties

Calculated from the sequence
FormulaC35H48N10O15
Monoisotopic mass848.3301 Da
Extinction coefficient at 280 nm5500 M⁻¹ cm⁻¹
A280 at 1 mg/mL6.480
Residues9
Average mass848.81 Da
pI4.09 (theoretical)
Identity
AliasesDelta sleep-inducing peptide
SequenceWAGGDASGE
Research areaNeurological

Property basis and sources

These describe the reference compound or formulation, not identification or testing of the supplied lot.

Calculation scope: the stored canonical amino-acid sequence with free N- and C-termini, no other modifications or counterions. This specifies a reference form, not the chemical form or identity of a sold lot.

  • Residues: 9 (calculated). Count of residues in the stored canonical reference sequence; terminal groups are not extra residues. Residues source 1
  • Average mass: 848.81 Da (calculated). Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded. Average mass source 1 Average mass source 2 Average mass source 3
  • pI: 4.09 (theoretical) (calculated). Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation. pI source 1 pI source 2

Residue composition

Unique residues
6
Most common
Glycine
Nonpolar residues
0
Other classified residues
9

Glycine is the most common residue (3). The calculated charge at pH 7 is net negative (-2.01).

Reference scope and linked records

Reference type: Peptide.

This is a research-reference entry, not a product certificate, treatment recommendation or administration guide. The sources below describe their own materials and methods. Catalogue identity, lot testing and clinical evidence are separate questions.

Catalogue context: DSIP. The product retains its own name and specification; this link does not certify equivalence to published study material.

Related references

Sources and their scope

  1. DSIP: amino-acid analysis, sequence, synthesis and activity. Source for the chemistry or study context discussed above; not an Aminos lot certificate.

Source check: 26 September 2026. This is an editorial source check, not a claim of independent clinical or laboratory review.

About DSIP

Identity and context

The original chemical study identified the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. It compared the synthetic peptide with possible metabolites and analogues, including an aspartyl isomer. This makes DSIP a useful example of why composition alone cannot establish the intended peptide identity.

Reference classification

Peptide. The linked catalogue product is DSIP. This reference does not independently authenticate the material supplied.

Storage and handling

Analytical specification

Confirm the sequence and linkage identity, not just total molecular mass. Isomeric material may need a resolving analytical method because a matching mass is not sufficient to establish the intended structure.

Storage and experimental handling

Use the documented conditions for the actual chemical form and preparation. No universal storage temperature, expiry or solution shelf life is assigned here. Follow the lot documentation, safety data sheet and validated laboratory protocol; this page is not a reconstitution or administration guide.

Research evidence

Research evidence for this compound
AreaSummaryEvidence
What the source examinesThe investigators evaluated EEG activity in rabbits under blinded experimental conditions. The reported delta and spindle effects were associated with the specified synthetic peptide. The study also distinguished the active alpha-aspartyl form from its beta-Asp isomer.Source context
What cannot be inferredThis is an animal experiment, not evidence that a catalogue preparation treats insomnia. No broad claim about present regulatory status or universal sleep physiology is inferred from the historical paper.Evidence limits

References

Sources used for the data on this page, checked September 2026.

  1. DSIP: amino-acid analysis, sequence, synthesis and activityPrimary source for the reference discussion; not lot-specific product evidence.

Reference information only. This page describes the chemistry and published research context of a laboratory compound. Nothing here is medical or dosing advice. Aminos compounds are for laboratory research use only and are not medicines.